DE2426682A1 - Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben - Google Patents

Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben

Info

Publication number
DE2426682A1
DE2426682A1 DE19742426682 DE2426682A DE2426682A1 DE 2426682 A1 DE2426682 A1 DE 2426682A1 DE 19742426682 DE19742426682 DE 19742426682 DE 2426682 A DE2426682 A DE 2426682A DE 2426682 A1 DE2426682 A1 DE 2426682A1
Authority
DE
Germany
Prior art keywords
general formula
adenosine
adenosine derivatives
acceptable salts
cyclopentyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19742426682
Other languages
German (de)
English (en)
Inventor
Erich Dr Techn Fauland
Wolfgang Dr Rer Nat Kampe
Wolfgang Prof Dr Med Schaumann
Harald Dr Med Stork
Max Dr Rer Nat Thiel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Priority to DE19742426682 priority Critical patent/DE2426682A1/de
Priority to BE156720A priority patent/BE829498A/xx
Priority to FI751527A priority patent/FI751527A7/fi
Priority to SE7506024A priority patent/SE7506024L/xx
Priority to JP50064780A priority patent/JPS511493A/ja
Priority to FR7516924A priority patent/FR2272678A1/fr
Priority to NL7506427A priority patent/NL7506427A/xx
Publication of DE2426682A1 publication Critical patent/DE2426682A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE19742426682 1974-06-01 1974-06-01 Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben Pending DE2426682A1 (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
DE19742426682 DE2426682A1 (de) 1974-06-01 1974-06-01 Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
BE156720A BE829498A (fr) 1974-06-01 1975-05-26 Nouveaux derives d'adenosine n(6)-disubstitues et procede pour leur preparation
FI751527A FI751527A7 (enExample) 1974-06-01 1975-05-26
SE7506024A SE7506024L (sv) 1974-06-01 1975-05-27 Forfarande for framstellning av nya n(6)-disubstituerade adenosin-derivat
JP50064780A JPS511493A (en) 1974-06-01 1975-05-29 Shinki n*6** nichikanadenoshinjudotainoseiho
FR7516924A FR2272678A1 (en) 1974-06-01 1975-05-30 N(6)-Disubstd. adenosine derivs - prepd. by reacting 6-(reactively substd.) purine ribosides with secondary amines
NL7506427A NL7506427A (nl) 1974-06-01 1975-05-30 Werkwijze ter bereiding van nieuwe n(6)-digesub- stitueerde adenosinederivaten.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742426682 DE2426682A1 (de) 1974-06-01 1974-06-01 Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben

Publications (1)

Publication Number Publication Date
DE2426682A1 true DE2426682A1 (de) 1975-12-11

Family

ID=5917125

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19742426682 Pending DE2426682A1 (de) 1974-06-01 1974-06-01 Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben

Country Status (7)

Country Link
JP (1) JPS511493A (enExample)
BE (1) BE829498A (enExample)
DE (1) DE2426682A1 (enExample)
FI (1) FI751527A7 (enExample)
FR (1) FR2272678A1 (enExample)
NL (1) NL7506427A (enExample)
SE (1) SE7506024L (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600707A (en) * 1985-01-25 1986-07-15 Warner-Lambert Company Benzothien-3-yl adenosine; benzothien-3-yl adenosine, S-oxide; and benzothien-3-yl, S,S-dioxide adenosine compounds
US4636493A (en) * 1985-01-25 1987-01-13 Warner-Lambert Company Benzothien-3-yl adenosine; benzothien-3-yl adenosine, S-oxide; and benzothien-3-yl, S,S-dioxide adenosine compounds
US4657897A (en) * 1984-06-22 1987-04-14 Warner-Lambert Company N6 -substituted adenosines for treating pain
US5032583A (en) * 1987-12-23 1991-07-16 Glaxo Group Limited 2,N-6-disubstituted adenosines and their antihypertensive methods of use
US5043325A (en) * 1984-04-18 1991-08-27 Whitby Research, Inc. N-6 substituted adenosine derivatives as cardiac vasodilators

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52108721A (en) * 1976-03-08 1977-09-12 Nippon Telegr & Teleph Corp <Ntt> Generating method of time series signal having memory function

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043325A (en) * 1984-04-18 1991-08-27 Whitby Research, Inc. N-6 substituted adenosine derivatives as cardiac vasodilators
US4657897A (en) * 1984-06-22 1987-04-14 Warner-Lambert Company N6 -substituted adenosines for treating pain
US4600707A (en) * 1985-01-25 1986-07-15 Warner-Lambert Company Benzothien-3-yl adenosine; benzothien-3-yl adenosine, S-oxide; and benzothien-3-yl, S,S-dioxide adenosine compounds
US4636493A (en) * 1985-01-25 1987-01-13 Warner-Lambert Company Benzothien-3-yl adenosine; benzothien-3-yl adenosine, S-oxide; and benzothien-3-yl, S,S-dioxide adenosine compounds
US5032583A (en) * 1987-12-23 1991-07-16 Glaxo Group Limited 2,N-6-disubstituted adenosines and their antihypertensive methods of use

Also Published As

Publication number Publication date
FR2272678A1 (en) 1975-12-26
SE7506024L (sv) 1975-12-02
JPS511493A (en) 1976-01-08
NL7506427A (nl) 1975-12-03
FI751527A7 (enExample) 1975-12-02
BE829498A (fr) 1975-11-26

Similar Documents

Publication Publication Date Title
EP0212535B1 (de) N6-Disubstituierte Purinderivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE69412322T2 (de) Xanthin-Derivate
DE3001328C2 (enExample)
DE69130869T2 (de) Xanthinderivate
DE2818676A1 (de) Substituierte 5,6-dimethylpyrrolo 2,3-d pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0316704A2 (de) Fluorcytidinderivate, deren Herstellung und Arzneimittel, die diese Derivate enthalten
DE2415763A1 (de) Neue benzochinolizine, verfahren zu ihrer herstellung und diese enthaltende mittel
DE2720085C2 (enExample)
DE2918261C2 (enExample)
EP1368313B1 (de) Verfahren zur herstellung von nicht hydratisiertem fexofenadin-hydrochlorid in form eines neuen polymorphs
DE2426682A1 (de) Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE1795357A1 (de) 2-Thio-pyrimidin-nucleoside
DE1962757C3 (de) Evomonosid-Derivate, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel
EP0096279A1 (de) N-(2-Methoxyethyl)-noroxymorphon, dessen Säureadditionssalze, diese enthaltende Arzneimittel und Verfahren zu deren Herstellung
EP0233483A2 (de) Pyrrolo[1,2-a][4,1]benzoxazepine, Verfahren zur ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie therapeutische Verwendung
DE2238923A1 (de) Acylierte n(6)-aralkyl-adenosinderivate und verfahren zur herstellung derselben
DE3606634A1 (de) Isohexid-nucleoside, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3111951A1 (de) 7(alpha)-alkoxycarbonyl-15ss-methylen-4-androstene, verfahren zu ihrer herstellung und verwendung als arzneimittel
EP0393499A1 (de) Verfahren zur Herstellung von Carbovir und neue Zwischenprodukte dafür
DE2244328A1 (de) Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2157036A1 (de) Neue heterocyclisch substituierte nebularin-derivate und verfahren zu deren herstellung
DD141310A5 (de) Verfahren zur herstellung von neuen purin-derivaten
DE2638828A1 (de) Neue thieno-pyridine
DE19610667C2 (de) (Z)-11ß-[4-(Dimethylamino)phenyl]17ß-hydroxy-17alpha-(3-hydroxy-1-propenyl)estr-4-en-3-on als kristallines Ansolvat
DE1130440B (de) Verfahren zur Herstellung von 2-Aminomethylderivaten von ?-3-Keto-steroiden